BioSpace News Archive

Drug Development

ASCO2016: Merck & Co. Release: New Data Evaluating KEYTRUDA (Pembrolizumab) In Combination With Chemotherapy For First-Line Treatment Of Non-Small Cell Lung Cancer Demonstrate Response Rates Ranging From 48 To 71 Percent

June 6, 2016
·
9 min read
Genetown

Ironwood To Present At Jefferies 2016 Healthcare Conference

June 6, 2016
·
1 min read
Drug Development

ASCO2016: VAXIMM Presents Data From Phase I Trial In Pancreatic Cancer With Oral T-Cell Immunotherapy VXM01 At ASCO 2016 Annual Meeting

June 6, 2016
·
5 min read
Business

Forentis Fund Launched To Bring Personalized Medical Solutions To Market

June 6, 2016
·
2 min read
Drug Development

Phase III Study Shows Genentech’s Actemra (Tocilizumab) Maintained Steroid-Free Remission In People With Giant Cell Arteritis (GCA)

June 6, 2016
·
6 min read
Drug Development

ASCO2016: Peloton Therapeutics Presents Clinical Data On First-In-Class Oral HIF-2a Inhibitor In Patients With Advanced Kidney Cancer At 2016 ASCO Annual Meeting

June 6, 2016
·
4 min read
BioMidwest

ASCO2016: Myriad Genetics myRisk Hereditary Cancer Test Demonstrates The Magnitude Of Breast And Ovarian Cancer Risk In Nearly 100,000 Patients

June 6, 2016
·
8 min read
Drug Development

ASCO2016: Ariad Presents Data From Mutational Profiling In Crizotinib-Resistant Patients Treated With Investigational Medicine Brigatinib Showing Similar Response Rates In Patients With And Without Secondary ALK Mutations

June 6, 2016
·
5 min read
Business

Chase Pharma Continues To Build Its Senior Leadership Team With Appointment Of Two Healthcare Industry Veterans

June 6, 2016
·
6 min read
Biotech Beach

Phenomenex, Inc. Release: ß-Gone Sorbent Delivers Fast, One-Step ?-Glucuronidase Removal From Hydrolyzed Urine

June 6, 2016
·
1 min read